Primary intracranial hemorrhage presenting as acute myocardial infarction: a contraindication to thrombolytic therapy

Kitching, Allan D.; Bernstein, Mark; O'Kelly, Brian F.
February 1994
CMAJ: Canadian Medical Association Journal;2/15/1994, Vol. 150 Issue 4, p519
Academic Journal
No abstract available.


Related Articles

  • Bleeding during Thrombolytic Therapy for Acute Myocardial Infarction: Mechanisms and Management. Sane, David; Califf, Robert; Topol, Eric; Stump, David; Mark, Daniel; Greenberg, Charles // Annals of Internal Medicine;12/15/89, Vol. 111 Issue 12, p1010 

    Presents a study on the management of patients who are receiving thrombolytic therapy for acute myocardial infarction. Adverse effect of thrombolytic therapy; Conditions associated with the risk of hemorrhage; Pharmaceutical agents for lysing pathologic thrombi; Principles of transfusion therapy.

  • Prospective evaluation of eligibility for thrombolytic therapy in acute myocardial infarction. French, John K.; Williams, Barbara F. // BMJ: British Medical Journal (International Edition);6/29/96, Vol. 312 Issue 7047, p1637 

    Determines the proportion of patients presenting with acute myocardial infarction who are eligible for thrombolytic therapy in Auckland, New Zealand. Eligibility for thrombolytic therapy; Mortality rates of myocardial infarction patients; Cautions with thrombolytic therapy. INSET: Key messages..

  • Thrombolysis for Evolving Myocardial Infarction.  // Annals of Internal Medicine;Sep85, Vol. 103 Issue 3, p463 

    Examines the application of thrombolytic therapy for evolving myocardial infarction. Role of coronary thrombosis in the pathogenesis of acute myocardial infarction; Objectives of thrombolytic therapy; Risks of thrombolytic therapy.

  • Could PTCA be the treatment of choice following MI? Rodman, Morton J.; Hurley, Mary Lou // RN;Nov93, Vol. 56 Issue 11, p85 

    Reports on the effectiveness of percutaneous transluminal coronary angioplasty (PTCA) in treating patients following an acute myocardial infarction (MI). Comparison with thrombolytic therapy; Publication of studies in the 1993 issue of the `New England Journal of Medicine'; Effect on rate of...

  • Myocardial infarction in the elderly: benefits and risks of thrombolytics. Aronow, W.S.; Aronow, Wilbert S // Drug Safety;Aug2002, Vol. 25 Issue 11, p753 

    Patients aged 75 years and older comprise 36% of all patients with myocardial infarction and 60% of all deaths from myocardial infarction in the US. Data from randomised, placebo-controlled clinical trials and observational data demonstrated a beneficial effect of thrombolytic therapy in...

  • Tenecteplase.  // Reactions Weekly;7/13/2013, Issue 1461, p35 

    An abstract of the article "Intracranial haemorrhage 4 days after receiving thrombolytic therapy in a young woman with myocardial infarction," by S. M. Ali and colleagues is presented.

  • Free-Wall Rupture of the Myocardium Following Infarction: A Changing Clinical Portrait in the Reperfusion Era: A Case Report. Weissman, Gaby; Kwon, Christopher C.; Shaw, Richard K.; Setaro, John F. // Angiology;Oct/Nov2006, Vol. 57 Issue 5, p636 

    Free wall rupture of the myocardium is an important complication and major cause of death following acute transmural (ST segment elevation) myocardial infarction. Pathologic changes on a cellular level may combine with mechanical stressors to weaken the myocardium postinfarction. Risk factors...

  • Coronary angioplasty vs. thrombolytic therapy. Huffman, Grace Brooke // American Family Physician;4/15/1998, Vol. 57 Issue 8, p1942 

    Presents the summary `Comparison of primary coronary angioplasty and intravenous thrombolytic therapy for acute myocardial infarction: A quantitative review,' by W.D. Weaver, et al which can be found in the JAMA dated December 1997.

  • Expanding the use of thrombolytic therapy for acute myocardial infarction. Kennedy, J. Ward; Kennedy, J W // Annals of Internal Medicine;12/15/90, Vol. 113 Issue 12, p907 

    Editorial. Discusses the expansion of thrombolytic therapy utilization in patients with acute myocardial infarction. Impression on thrombolytic therapy for acute myocardial infarction in the U.S.; Ways to increase the number of thrombolytic therapy utilization for acute myocardial infarction;...

  • A milestone for myocardial infarction. Julian, Desmond G.; Pentecost, Brian L.; Chamberlain, Douglas A. // BMJ: British Medical Journal (International Edition);8/20/88-8/27/88, Vol. 297 Issue 6647, p497 

    Evaluates the effects of aspirin and thrombolytic treatment on acute myocardial infarction treatment. Advantages and disadvantages of thrombolytic treatment; Important contraindication to thrombolytic treatments; Assessment on the thrombolytic agents for streptokinase.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics